The United Kingdom Childhood Cancer Study was designed to examine the relation between childhood cancer and preceding exposure to infectious diseases. The authors analyzed the relation between diagnosis (1991)(1992)(1993)(1994)(1995)(1996) of acute lymphoblastic leukemia (ALL) at ages 2-5 years and clinically diagnosed infections in infancy. Almost all study children (96% of both cases and controls) were taken to a general practitioner for a non-immunizationassociated visit at least once before their first birthday. Children diagnosed with ALL had significantly more clinically diagnosed infectious episodes in infancy than did controls; the average number of episodes was 3.6 (95% confidence interval (CI): 3.3, 3.9) versus 3.1 (95% CI: 2.9, 3.2). This case-control difference was most apparent in the neonatal period (1 month); 18% of controls and 24% of ALL cases were diagnosed with at least one infection (odds ratio ¼ 1.4, 95% CI: 1.1, 1.9; p < 0.05). Cases who had more than one neonatal infectious episode tended to be diagnosed with ALL at a comparatively young age; the mean age at ALL diagnosis was 37.7 months for cases with two or more episodes versus 45.3 months for cases with only one episode or none (p < 0.01). These findings support the hypothesis that a dysregulated immune response to infection in the first few months of life promotes transition to overt ALL later in childhood.
Infections are estimated to account for 15-20 percent of cancers worldwide, and the proposition that the timing and pattern of infectious disease exposure could be a determinant of the type of leukemia commonly seen in children is not new (1) (2) (3) (4) (5) (6) . At present, however, no specific agents have been identified, and exactly how in-utero and postnatal infectious exposures might affect the likelihood of subsequent leukemia development in children remains a much debated topic (7) (8) (9) .
The United Kingdom Childhood Cancer Study (UKCCS) was specifically designed to investigate the potential etiologic role of infections as one of its objectives (10) . The main hypothesis was that acute lymphoblastic leukemia (ALL) could arise as a rare abnormal response to a common infection (10) . The two postulated mechanisms as to how this might occur have become known as the ''Kinlen'' and ''Greaves'' hypotheses, after their respective architects. The former speculates that acute leukemia, and possibly nonBurkitt's lymphoma, could arise as a consequence of exposure to a specific infection, particularly evident at times of unusual population movement and mixing (8, 11) . The latter, which forms the focus of the present report, proposes that a deficit of exposure to infectious agents in infancy and subsequent ''delayed'' infectious challenge may be causal in the development of B-cell precursor common ALL, which, with its characteristic peak at ages 2-5 years, accounts for approximately 75 percent of ALLs diagnosed in children (4, 12) .
Unraveling the relation between any individual person's cancer risk and his or her history of exposure to infectious agents and response to infectious challenge is fraught with difficulties. For children, a bewildering array of proxy measures aimed at quantifying their likely exposure to infectious agents at various time points have been used, including measures of family socioeconomic status and urban/rural location (13, 14) ; indicators of parental social contact outside the home, such as occupation, migration, and distance traveled to work (15) (16) (17) (18) ; and markers of the child's own social activity, including birth order and maternally reported child-care attendance outside the home, together with illness history and immunization (13, (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) .
We examined the relation between clinically diagnosed infections in infancy and subsequent leukemia development among children in the UKCCS. These data were systematically abstracted from primary-care records compiled before diagnosis/interview. The ability to access medical records in this way is a unique facet of the organization of the United Kingdom health care system. In this paper, we provide important background information on the conduct of this component of the study. We describe the main findings relating to acute leukemia diagnosed in the peak years (ages 2-5 years) and its relation with clinically diagnosed infection in the first year of life.
MATERIALS AND METHODS
The UKCCS is a national population-based case-control study. Its conduct and ethical approval are described in detail elsewhere (10) . Briefly, children aged 0-14 years diagnosed with ALL between 1991 and 1996 in Great Britain were eligible. For each case, two controls matched by sex, month and year of birth, and region of residence at diagnosis were randomly recruited from primary-care population registers. At interview, parents were asked to consent to our access of their child's primary-care records. For each child, all information contained within these routinely compiled health records from birth to diagnosis (using a pseudo-diagnosis date for control children) was subsequently abstracted onto specially designed forms by centrally trained research staff (29) .
The data collected included all diagnoses recorded contemporaneously by the child's general practitioner (i.e., primarycare physician), as well as all signs and symptoms recorded at the same time; referrals to hospital consultants and other specialists; results of all investigations; and detailed information on all medicines and other treatments prescribed. Data collection and entry were structured around dated ''events'' (e.g., general practitioner consultation, hospital admission, blood tests, screening procedures), with all data being entered centrally under the supervision of experienced primary-care research nurses. Disease and drug coding are key issues in handling and analysis of such data-adopting a unified approach facilitates coding, and this has been achieved using a sophisticated system of computerized ''pick-lists'' embedded in the data-entry program. Illnesses and symptoms were centrally coded according to the International Classification of Diseases, Tenth Revision (30) , and drugs were coded according to a schema based on the British National Formulary (31) . Strict quality control procedures, including duplicate data entry of approximately one in four randomly selected records, were used throughout by one of the authors (P. A.).
For the purposes of study management, 10 UKCCS administrative areas were created; the conduct of the study within each area was the responsibility of a single epidemiologic center. Six of the 10 UKCCS centers systematically collected primary-care records from within their area, but each in a different way (see footnotes to table 1). Overall, the primary-care (general practitioner) records of 1,567 (92 percent) targeted case children with cancer and 2,393 (70 percent) control children without cancer were traced and abstracted (table 1). All cases had information on at least one of their matched controls abstracted, and more than half had information on both. The lower overall control proportion (70 percent of controls vs. 92 percent of cases) reflects regional policy variation with respect to the abstraction of data on the number of controls sought. Only one region (Oxford) routinely abstracted data on both controls; others opted for one control per case at varying times as the study progressed-Leeds, Manchester, and Cambridge doing so almost from the outset and Edinburgh and Southampton changing the procedure part-way through. Importantly, as with other components of the UKCCS that only collected additional data on one of the two individually matched controls, this control-the lowest numbered (first randomly selected) interviewed control in the series-was identified in advance of abstraction (32) .
Infections occurring in the first year of life among children who subsequently developed leukemia between 2 and 5 years of age form the focus of the present report; these data are presented in the bottom half of table 1. Sixteen of the 471 case children also had Down's syndrome and were excluded from further analyses because of the known relations both between Down's syndrome and leukemia and between Down's syndrome and childhood infection (33) .
We calculated enumeration district ''deprivation'' indices for the UKCCS administrative areas contributing to these analyses using the same methods as described for the United Kingdom as a whole (10) . As in previous UKCCS publications (23, 24, (34) (35) (36) , in order to increase precision and statistical power we used all available controls as the comparison group in the main analyses. Odds ratios, 95 percent confidence intervals, and two-sided p values were estimated using unconditional logistic regression, with adjustment for UKCCS administrative area of residence at diagnosis, sex, and age (in single years) at diagnosis (37) . In order to check the veracity of our findings with respect to misclassification and/or selection bias, we repeated the analyses using conditional logistic regression and data from the Oxford region (100 percent of leukemias diagnosed at ages 2-5 years and 98.3 percent of matched controls). All analyses were conducted using Stata software (38) .
RESULTS
Of the 455 children with leukemia diagnosed between 2 and 5 years of age, 425 (93.4 percent) had ALL; 342 (80.5 percent) of these ALLs were B-cell precursor common ALL. Findings for these three overlapping groups are presented in the tables and figures, and results for ALL are highlighted in the text.
Information on sociodemographic characteristics and primary-care consultations in the first 12 months of life is given in table 2. There were no statistically significant differences between cases and controls for any of the factors presented. The use of all available controls resulted in small differences between cases and controls with regard to the original matching factors-age and sex-and adjustment for both of these factors, along with UKCCS administrative area, was included a priori in all risk ratio estimate calculations. The socioeconomic area-based deprivation distributions of case and control families included in the analysis were similar, and no subsequent adjustments were required.
All children in the study were taken to their general practitioner at least once during the first year of life, but a few only visited for routine immunization. Overall, 95.7 percent of control children and 95.8 percent of case children made at least one non-immunization-associated visit to their general practitioner before their first birthday. No systematic variations between cases and controls were observed when the data were distributed by leukemia subtype, deprivation category, and UKCCS administrative area (table 2) .
Children who subsequently developed leukemia between ages 2 and 5 years visited their general practitioner marginally more frequently during the first year of their life than children who did not; the average numbers of visits per child were 7.8 (95 percent confidence interval (CI): 7.2, 8.4) and 6.9 (95 percent CI: 6.6, 7.2) for ALL cases and controls, respectively (table 3) . This difference reflects the fact that children who developed leukemia were significantly more likely (p < 0.05) to visit the general practitioner with an infection and/or symptoms consistent with an infection (fever or pyrexia, vomiting, cough, and rash); the average numbers of visits per child were 4.5 (95 percent CI: 4.2, 4.9) and 3.9 (95 percent CI: 3.7, 4.1) for ALL cases and controls, respectively. Findings were similar when consultations involving potentially infectious symptoms but with no definitive diagnoses were excluded: The average number of visits with a clinically diagnosed infection was 3.6 (95 percent CI: 3.3, 3.9) for children with ALL and 3.1 (95 percent CI: 2.9, 3.2) for controls. For other types of consultation (e.g., routine health checks and follow-up visits, feeding problems, general irritability, diaper (nappy) rash, etc.), no significant differences were observed; the average number of visits totaled approximately three in controls and just over three in all leukemia groups. The excess of clinically diagnosed infection in children who developed leukemia between ages 2 and 5 years is apparent from the first month of life (the neonatal period), as can be seen from table 4, where data on total infections are accompanied by data on the six most commonly diagnosed infant infections. Overall, 18 percent of controls and 24 percent of ALL cases were diagnosed with at least one infection during their first month of life (odds ratio (OR) ¼ The increase in risk associated with early infection appeared to be fairly generalized, and with the exception of infections of the lower respiratory tract, all of the odds ratios shown in table 4 are raised. However, the type of infection diagnosed in infancy varied with age. Fungal conditions tended to occur early (the median age at first diagnosis was 2.5 months in controls), and the odds ratios for ALL were 1.9 (95 percent CI: 1.1, 3.2; p ¼ 0.025) and 1.4 (95 percent CI: 1.0, 1.9; p ¼ 0.035) for the first month and the first year of life, respectively. In our data, all case children diagnosed with a fungal infection in the first 12 months of life had Candida albicans of the mouth and/or skin, as did all but two of the controls (both of whom had tinea or ''ringworm''). Only four (7 percent) of the neonates (two controls and two cases with ALL) had received an antibiotic prescription preceding their fungal diagnosis. While fungal conditions are comparatively easy to diagnose, separating conditions of viral origin from those of bacterial origin is not straightforward at any age and is particularly difficult in young babies. For example, while it seems likely that most of the upper respiratory tract infections were viral (for ALL diagnosed at age 12 months, OR ¼ 1.3, 95 percent CI: 1.0, 1.7; p ¼ 0.024) and most of the ear infections (otitis media) were bacterial (for ALL diagnosed at age 12 months, OR ¼ 1.2, 95 percent CI: 0.9, 1.6), some will have had other causes and those of the gastrointestinal tract will have had mixed etiologies. Accordingly, further separation of the data by agent was not attempted. As can be seen from figure 1, children who visited their general practitioner more than once with a neonatal infection tended to be diagnosed with ALL approximately 7 months earlier than children with only one infection or no infections (p < 0.01). With respect to cytogenetic subtype, data were available for 365 (86 percent) children diagnosed with ALL between 2 and 5 years of age. Within this group, no obvious differences between the types of leukemia among children who had infections and those who did not were apparent (p > 0.05). Furthermore, the findings did not vary by UKCCS administrative region, number of controls per case (two or one), or method of analysis (unconditional or conditional logistic regression). Reassuringly, with respect to the latter two factors, the odds ratios for the Oxford region (100 percent of cases and 98.3 percent of controls) for neonatal infections were 2.1 (95 percent CI: 1.1, 4.1; p ¼ 0.022) and 1.9 (95 percent CI: 1.1, 3.5; p ¼ 0.031) as calculated by conditional and unconditional (adjusted for matching variables) logistic regression, respectively.
DISCUSSION
In the UKCCS, we found that children who developed ALL at the diagnostic peak, between the ages of 2 and 5 years, had more clinically diagnosed infections in the first year of life than unaffected children. This excess was apparent from the first month of life, with children with more than one neonatal episode of infectious illness developing their leukemia at a younger age than children with only one episode or none. In this context, it is important to remember that our analyses were restricted to leukemias diagnosed between the ages of 2 and 5 years-hence, the interval between neonatal infection and subsequent leukemia diagnosis was at least 23 months.
To our knowledge, the relation between clinically diagnosed infection in the first year of life and subsequent leukemia development has not been previously explored. In the absence of definitive serologic evidence, this measure is probably the most specific indicator of infection, since infectious illness requires infectious exposure. Clearly, however, not all exposures lead to symptoms, and not all symptoms result in a clinical diagnosis of illness. Indeed, even antibody detection does not yield information on timing, dose, or exposure to uncharacterized agents; and in this sense, it is impossible to directly test the delayed-infection hypothesis (9) .
The lack of obvious bias is critical to the interpretation of the analyses presented here. The data came from medical records compiled contemporaneously before diagnosis/ interview, and our findings were not affected by recall or reporting biases-problems that bedevil studies that rely on parental self-reporting (21, (25) (26) (27) (39) (40) (41) (42) . It also seems unlikely that our results could have been biased in any other way, since ascertainment was high (94 percent) for leukemias diagnosed between the ages of 2 and 5 years, with all cases having information from at least one of their UKCCS administrative area-matched controls. Furthermore, the deprivation distributions of cases and controls were similar (43) , and no evidence of any systematic socioeconomic variation in primary-care attendance patterns in the first year of life was found, either across the UKCCS as a whole or within any specific geographic area. The homogeneity of infant consultation patterns reported here and elsewhere (44, 45) contrasts with the pattern seen for older children, where sociodemographic circumstances influence some (46, 47) , but by no means all (48), health-care-seeking behaviors. Hence, while our findings for infant consultations are unlikely to have been biased by socioeconomic differences between cases and controls, this is less certain for other potential proxies of infectious disease exposure, such as parental occupation (15, 17, 18) , day-care attendance outside the home (24, 26, 27) , and infant feeding practices (49) .
Taken at face value, our results do not support our original hypothesis that a deficit of exposure to infectious agents-as measured here by clinically diagnosed illness early in life-is associated with an increased risk of ALL development (12) . Likewise, the generality of the increased risk observed across a range of infections seems counter to the notion of a specific leukemogenic agent (8) . However, the UKCCS broader hypothesis (10) on infection predicts that genetic susceptibility may underpin an abnormal immune response, and we have previously reported a positive association between B-cell precursor common ALL and certain human leukocyte antigen DP alleles (50). Other immune-response genes are currently being explored. Although the suggestion that pediatric ALL originates prenatally or within the first few weeks of life is not new (51) , there is now compelling molecular evidence that childhood ALL may be initiated in utero (52) (53) (54) . In this context, an abnormal or dysregulated immune response to infection after birth may promote subsequent genetic events required for transition to overt ALL (9) . Our previous analysis using formal day-care attendance as a proxy for early infections indicated that early exposure may, as predicted by the ''delayed infection'' hypothesis, provide some degree of protection against ALL (24) . Our current data argue somewhat differently and indicate that in at least some cases, early infection is positively associated with early-onset ALL. One possibility that merits further exploration is that an abnormal immune response to infection, promoting childhood ALL, can arise either as a result of a lack of exposure in infancy, with a consequent failure of immune network modulation, or as a result of a genetically biased immune response that may be independent of the timing of infectious disease exposure.
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